OpenVSafe by OpenVAERS
Search V-safe

9HW-23162-86354

3 vaccinations 7 coded responses 38 check-ins 7 free-text entries 0 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
631 / MO
Registered
2020-12-29
Relationship
Self
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-29
    Registered in v-safe
  2. 2020-12-29
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-29
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2020-12-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2020-12-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-05
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-01-18
    Dose 2 — Pfizer-BioNTech
  12. 2021-01-18
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  13. 2021-01-19
    Survey response — days 1–6 daily, dose 2
    MedDRA: Insomnia — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Difficulty staying asleep
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-01-20
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymph node pain — Feeling: Good · Site: Pain
    Free text: Tender lymph nodes, ipsilateral. Axillary, and maybe supraclavicular and occipital too?
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-01-21
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good
    Free text: Tender ipsilateral lymphadenopathy: axillary, supraclavicular, anterior and posterior cervical chain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-01-22
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good
    Free text: Tender swollen lymph nodes, ipsilateral - axillary, anterior and posterior cervical chain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-01-23
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymph node pain — Feeling: Good
    Free text: Mildly tender ipsilateral lymph nodes- axillary and cervical
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-01-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-01-25
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-02-01
    Survey response — day 14, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: My right-sided cervical lymphadenopathy resolved about 5 days after starting. It just recurred last night, but is not as prominent as before.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-02-08
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-15
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-02-22
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-03-01
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-04-19
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-07-19
    Survey response — 6 months, dose 2
    MedDRA: Respiratory symptom — Feeling: Good
    Free text: 4 days of upper respiratory infection symptoms approximately 3 weeks ago
    MedDRA releases: 2024-11 · check-in free text available
  27. 2021-10-01
    Dose 3 — Pfizer-BioNTech
  28. 2021-10-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  29. 2021-10-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  30. 2021-10-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Fever · Fatigue or tiredness
    Adult check-in
  31. 2021-10-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Muscle or body aches
    Adult check-in
  32. 2021-10-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Fatigue or tiredness, Nausea
    Adult check-in
  33. 2021-10-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  34. 2021-10-08
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2021-10-15
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  36. 2021-10-22
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  37. 2021-10-29
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-11-05
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  39. 2021-11-12
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  40. 2021-12-31
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  41. 2022-04-01
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  42. 2022-10-01
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-29Pfizer-BioNTech
22021-01-18Pfizer-BioNTech
32021-10-01Pfizer-BioNTech No

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-19

Systemic reaction (other): Difficulty staying asleep

2021-01-20

Systemic reaction (other): Tender lymph nodes, ipsilateral. Axillary, and maybe supraclavicular and occipital too?

2021-01-21

Systemic reaction (other): Tender ipsilateral lymphadenopathy: axillary, supraclavicular, anterior and posterior cervical chain

2021-01-22

Systemic reaction (other): Tender swollen lymph nodes, ipsilateral - axillary, anterior and posterior cervical chain

2021-01-23

Systemic reaction (other): Mildly tender ipsilateral lymph nodes- axillary and cervical

Release 3 — day 14, dose 2

2021-02-01

Symptoms: My right-sided cervical lymphadenopathy resolved about 5 days after starting. It just recurred last night, but is not as prominent as before.

Release 9 — 6 months, dose 2

2021-07-19

Symptoms: 4 days of upper respiratory infection symptoms approximately 3 weeks ago

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDLymphadenopathy ✓ ✓ ✓
SDRespiratory symptom · · ✓
SROInsomnia ✓ ✓ ✓
SROLymph node pain ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release